Showing results (101-110 of 145) with videos related to
Sort By:
Pageof 15
Oncotarget|September 15, 2018
Beyond the 3'UTR binding-microRNA-induced protein truncation via DNA bindingMelanie von Brandenstein, Stephan H Bernhart, Andreas Pansky, et al.Scientific Reports|February 3, 2016
Gene profiling of embryonic skeletal muscle lacking type I ryanodine receptor Ca(2+) release channelDilyana Filipova, Anna M Walter, John A Gaspar, et al.World Neurosurgery|August 3, 2021
Clinical Characteristics and Magnetic Resonance Imaging-Based Prediction of the KLF4K409Q Mutation in MeningiomaNiklas von Spreckelsen, Natalie Waldt, Marco Timmer, et al.Journal of Neuro-Oncology|June 18, 2022
Efficacy and tolerability of regorafenib in pretreated patients with progressive CNS grade 3 or 4 gliomasJan-Michael Werner, Lena Wolf, Caroline Tscherpel, et al.Cellular & Molecular Immunology|February 7, 2020
The deubiquitinase OTUB1 augments NF-κB-dependent immune responses in dendritic cells in infection and inflammation by stabilizing UBC13Floriana Mulas, Xu Wang, Shanshan Song, et al.Aging Cell|November 7, 2019
A tissue-specific screen of ceramide expression in aged mice identifies ceramide synthase-1 and ceramide synthase-5 as potential regulators of fiber size and strength in skeletal muscleBettina Tosetti, Susanne Brodesser, Anna Brunn, et al.Journal of Neuropathology and Experimental Neurology|July 4, 2008
Recurrent inactivation of the PRDM1 gene in primary central nervous system lymphomaCornelius Courts, Manuel Montesinos-Rongen, Anna Brunn, et al.The American Journal of Pathology|May 28, 2005
Absence of immunoglobulin class switch in primary lymphomas of the central nervous systemManuel Montesinos-Rongen, Roland Schmitz, Cornelius Courts, et al.European Journal of Haematology|May 7, 2021
Treatment patterns and disease course of previously untreated Primary Central Nervous System Lymphoma: Feasibility of MTX-based regimens in clinical routineNoëlle Sieg, Jan-Hendrik Naendrup, Philipp Gödel, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|April 26, 2007
Bystander killing of malignant glioma by bone marrow-derived tumor-infiltrating progenitor cells expressing a suicide geneHrvoje Miletic, Yvonne Fischer, Sara Litwak, et al.Pageof 15